IMPURITIES AVAILABLE FOR 'Velpatasvir'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Velpatasvir. Velpatasvir is a direct-acting antiviral agent used in combination with sofosbuvir for the treatment of chronic hepatitis C virus (HCV) infection across all major genotypes (1–6). It works by inhibiting the HCV NS5A protein, which is essential for viral RNA replication and assembly. Velpatasvir is part of a fixed-dose combination tablet that offers a highly effective, once-daily, interferon-free treatment regimen. It has demonstrated high cure rates (sustained virologic response, SVR) with minimal side effects. Common adverse reactions include headache, fatigue, nausea, and insomnia. It is generally well-tolerated and does not require ribavirin, making it suitable for a broad range of patients, including those with compensated cirrhosis. Drug interactions may occur with certain antacids, anticonvulsants, and P-gp inducers, so co-administration should be monitored. Velpatasvir has significantly improved the safety, efficacy, and accessibility of hepatitis C treatment. Buy high quality Velpatasvir from Omsynth Lifesciences.